Person: Dr Robert Grundel

Phil Baker

Phil Baker is stepping down as president and CEO of the Ontario Research and Innovation Network (ORION), a position he has held since establishing the organization in 2001. Baker is retiring after a 30-year career in the Ontario public service, where he played a key role in the development of Ontario’s broadband and networking strategies,…

Dr Robert Grundel

Dr Robert Grundel has been appointed VP R&D for Amorfix Life Sciences, a Toronto-based developer of treatments and diagnostics for brain-wasting diseases and cancer. Grundel comes to Amorfix with considerable experience in the pharmaceutical industry. Over the past 25 years he has held executive positions with Heat Biologics Inc, Miami Beach FL, Elusys Therapeutics Inc,…